These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 5303344

  • 1. [Progestagen therapy of menometrorrhagias caused by hemorrhagic diatheses].
    Rák K.
    Dtsch Med Wochenschr; 1968 Dec 13; 93(50):2436-9. PubMed ID: 5303344
    [No Abstract] [Full Text] [Related]

  • 2. [The role of ovulation inhibitors in the treatment of pathological uterine hemorrhage in women with hemorrhagic diathesis].
    R0ak K.
    Orv Hetil; 1967 Nov 05; 108(45):2116-20. PubMed ID: 5594940
    [No Abstract] [Full Text] [Related]

  • 3. Pubertal hemorrhages in girls with a hemorrhagic disorder. Comments on management.
    Van Creveld S, Schellekens LA.
    Clin Pediatr (Phila); 1969 Jul 05; 8(7):398-9. PubMed ID: 5305932
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical study of a synthetic progestagen at low doses].
    Gaudefroy M.
    Gynecol Prat; 1966 Jul 05; 17():337-43. PubMed ID: 5987259
    [No Abstract] [Full Text] [Related]

  • 5. [Oral contraceptives in the treatment of the meno-metrorrhagia of the solitary ovary syndrome after unilateral castration].
    Vasiliu V, Filipescu D.
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968 Jul 05; 20(5):Suppl:485-6. PubMed ID: 5759285
    [No Abstract] [Full Text] [Related]

  • 6. [On the problem of differential diagnosis of abnormal uterine hemorrhage].
    Otto H.
    Zentralbl Gynakol; 1966 Jan 29; 88(5):113-8. PubMed ID: 5973584
    [No Abstract] [Full Text] [Related]

  • 7. [Management of dysfunctional bleeding as well as hyper- and polymenorrheas using high doses of ovulation inhibitors].
    Soergel W.
    Geburtshilfe Frauenheilkd; 1969 Feb 29; 29(2):159-65. PubMed ID: 5386827
    [No Abstract] [Full Text] [Related]

  • 8. Bleeding disorders: A common cause of menorrhagia in adolescents.
    Bevan JA, Maloney KW, Hillery CA, Gill JC, Montgomery RR, Scott JP.
    J Pediatr; 2001 Jun 29; 138(6):856-61. PubMed ID: 11391329
    [Abstract] [Full Text] [Related]

  • 9. A clinical trial of a new totally synthetic low dose progestagen.
    Foss GL.
    J Reprod Fertil; 1969 Feb 29; 18(1):59-66. PubMed ID: 5797563
    [No Abstract] [Full Text] [Related]

  • 10. [Spaniomenorrhea and hypermenorrhea in the female adolescent. Aspects and management].
    Salomon-Bernard Y.
    Rev Fr Gynecol Obstet; 1986 May 29; 81(5):257-62. PubMed ID: 3526511
    [Abstract] [Full Text] [Related]

  • 11. [Changes in endometrium under the influence of various doses of lynestrenol (progestagen of the 3-deoxy-19-nor-testosterone group].
    Teter J, Jedrzejewski M, Krzywdziński K.
    Ginekol Pol; 1967 Dec 29; 38(12):1383-91. PubMed ID: 6081585
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of dysfunctional uterine hemorrhages and amenorrheas using a progestagen-estrogen combination].
    Brehm H, Karsznia R, Prinz W, Schmidt G.
    Med Monatsschr; 1972 Dec 29; 26(12):577-9. PubMed ID: 4663633
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy and care of patients with "juvenile metropathy"].
    Borsos A, Balogh A, Smid I, Takács I.
    Orv Hetil; 1975 Jun 01; 116(22):1277-9. PubMed ID: 124417
    [No Abstract] [Full Text] [Related]

  • 14. Platelet dysfunction.
    FRAZER AK.
    Lancet; 1959 Mar 07; 1(7071):502. PubMed ID: 13632066
    [No Abstract] [Full Text] [Related]

  • 15. [Appropriate laboratory investigation in women with menorrhagia].
    de Raucourt E, Ternisien C.
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec 07; 37 Suppl 8():S317-28. PubMed ID: 19268209
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A case of metrorrhagia associated with coagulation changes].
    ALBANO V, FERRARO C.
    Minerva Ginecol; 1955 Jun 30; 7(12):140-1. PubMed ID: 13253336
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of menstruation disorders in girls with gestagens].
    Komorowska A.
    Ginekol Pol; 1968 Jan 30; 39(1):59-66. PubMed ID: 5665494
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Administration of gestagens (Orgametril and Anovlar-21) in the treatment of hemorrhages caused by endometrial hyperplasia].
    Bartoszewski A, Borowicz C, Zbroja-Sontag W.
    Endokrynol Pol; 1969 Jan 30; 20(2):125-33. PubMed ID: 5782274
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.